Investing in Longevity 101

A new course will help navigate emerging field of longevity – an industry that is going to change the world.

Investing in a new mega trend can be challenging; as well as entering a new market, there is a great deal to learn and understand – new terminology, new science, new risks and new opportunities.

Investing in Longevity 101 is a new online course designed to help investors, and all those interested in participating in this new economy, to navigate the sector – this includes entrepreneurs, executives, clinicians, policy makers, &c.

Launching shortly, the course content for Investing in Longevity 101 addresses both longevity biotech and non-biotech, reflecting the current segmentation of the longevity market.

There are companies like supplement manufacturers, clinics and biomarker vendors that are raising capital and generating revenues today, and there are longevity biotechs that are progressing through clinical trial phases – a growing number of them ‘in human’. Plus, there are myriad companies not far behind, all looking for multiple millions in investment that can help them maintain their progress and accelerate to clinic or market.

Education is key, and really understanding the longevity space will help investors benefit from its incredible opportunities – and help longevity benefit from much-needed investment. We gathered the course founders – Evelyne Bischof, Phil Newman, Ricardo Gaminha Pacheco, Jiayi Song and Alex Zhavoronkov – round a virtual table to find out more.

------------------------------
Visit Longevity.Technology - https://bit.ly/3PwtH8Y

Follow Longevity.Technology on:
Twitter - https://bit.ly/3AMIXuq
Facebook - https://bit.ly/3z8H1v5
Instagram - https://bit.ly/3IDvVRX
Linkedin - https://bit.ly/3yIfDmf